medigraphic.com
ISSN 1870-199X (Print)
Órgano oficial de la Facultad de Odontología, UNAM

2017, Number 2

<< Back Next >>

Rev Odont Mex 2017; 21 (2)

Alterations found in the mouth of patients treated with head and neck radiotherapy. Medellin, Colombia

Álvarez GGJ, López CRV, Botero TJE, Botero GSM, Cardona ÁDP, Carmona RPA, Hernández AJE

Language: Spanish
References: 54
Page: 87-97
PDF size: 282.63 Kb.


ABSTRACT

The aim of the present study was to determine which oral alterations can be found in patients with head and neck cancer treated with radiotherapy as well as to explore dentist’s involvement in treatment of these patients. An exploratory study was conducted in 52 patients who had previously received over 1,000 cGy radiation. A survey was undertaken as well as oral examination of each participant, in order to assess stimulated salivary flow and flavor tests. Results revealed high prevalence of oral alterations in patients with accumulated radiation of 3,001-5,000 cGy. Dry mouth (xerostomia) was the most frequently reported alteration (78.8%). Estimated total salivary secretion rate confirmed a state of hyposalivation in 82.7% of all patients. A statistically significant association was found between cancer location (p ‹ 0.01) and type of tumor with presence of trismus (p ‹ 0.05). Hyposialia was more frequently present in patients with stage IV tumors (50%) in those subjected to combined treatments (p ‹ 0.05). Periodontal assessment was possible in 50% of all patients, Of this proportion, 92% exhibited periodontitis with mainly moderate to severe insertion loss; 84.6% of all participants reported not to have been remitted to dentists either before or after treatment. Findings support high frequency of oral alterations in patients subjected to radiotherapy treatment and dental care inappropriateness to prevent or treat these effects. An alert is raised with respect to the compulsiveness to follow treatment protocols for cancer patients, which should include dental evaluation before, during and after respective treatment.


REFERENCES

  1. Taibi R, Lleshi A, Barzan L, Fiorica F, Leghissa M, Vaccher E et al. Head and neck cancer survivors patients and late effects related to oncologic treatment: update of literature. Eur Rev Med Pharmacol Sci. 2014; 18: 1473-1481.

  2. Lovelace TL, Fox NF, Sood AJ, Nguyen SA, Day TA. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 117 (5): 595-607.

  3. Campos MI, Campos CN, Aarestrup FM, Aarestrup BJ. Oral mucositis in cancer treatment: natural history, prevention and treatment (review). Mol Clin Oncol. 2014; 2(3): 337-340.

  4. Axelsson P. Diagnosis and Risk Prediction of Dental Caries. Chicago: Quintessence Publishing Company; 2000. p. 307.

  5. Epstein JB, Pearsall NN, Truelove EL. Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects. J Clin Microbiol. 1980; 12 (3): 475-476.

  6. López-Castaño F, Oñate-Sánchez RE, Roldán-Chicano R, Cabrerizo-Merino MC. Measurement of secondary mucositis to oncohematologic treatment by means of different scale. Med Oral Patol Cir Bucal. 2005; 10(5): 412-21.

  7. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003; 14 (3): 199-212.

  8. Solanas A, Salfranca L, Fauquet J, Núñez M. Estadística Descriptiva en Ciencias del Comportamiento. Madrid: Thompson; 2005.

  9. Bernier J1, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005; 27 (10): 843-850.

  10. Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouraul with or without docetaxel for larynx preservation. J Natl Cancer Inst. 2009; 101: 498-506.

  11. Gupta S, Kong W, Booth CM, Mackillop WJ. Impact of concomitant chemotherapy on outcomes of radiation therapy for head and neck cancer: A population-based study. Int J Radiat Oncol Biol Phys. 2014; 88 (1): 115-121.

  12. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck for the radiation therapy oncology group 9501/Intergroup. N Engl J Med. 2004; 350: 1937-1944

  13. Instituto Nacional de Cancerología. Cáncer en cifras, Magnitud del cáncer en Colombia. [Internet]. [citado 14 de noviembre de 2015]. Recuperado a partir de: http://www.cancer.gov.co/cancer_en_cifras

  14. Correia B, Regina A. Oral complications of radiotherapy in the head and neck. Rev Bras Otorrinolaringol. 2006; 72 (5): 704-708.

  15. Wong H. Oral complications and management strategies for patients undergoing cancer therapy. Scientific World Journal. 2014; 2014 (2014:581795): 1-14.

  16. Fischer C, Devides N, Torsani L, Bortolucci Jr A, Lauris J, Fischer I et al. Evaluation of some oral postradiotherapy sequelae in patients treated for head and neck tumors. Braz Oral Res. 2007; 21 (3): 272-277.

  17. Kakoei S, Haghdoost AA, Rad M, Mohammadalizadeh S, Pourdamghan N, Nakhaei M et al. Xerostomia after radiotherapy and its effect on quality of life in head and neck cancer patients. Arch Iran Med. 2012; 15 (4): 214-218.

  18. Mod D, Mod H, Jha AK. Oral and dental complications of head and neck radiotherapy and their management. J Nepal Health Res Counc. 2013; 11 (25): 300-304.

  19. Ramirez-Amador V, Silverman S Jr, Mayer P, Tyler M, Quivey J. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 84 (2): 149-153.

  20. Grötz KA, Genitsariotis S, Vehling D, Al-Nawas B. Oral Candida colonization, mucositis and salivary function after head and neck radiotherapy. Support Care Cancer. 2003; 11: 717-721.

  21. Kurnatowski P, Moqbil S, Kaczmarczyk D. Signs, symptoms and the prevalence of fungi detected from the oral cavity and pharynx of radiotherapy subjects with head and neck tumors, and their susceptibility to chemotherapeutics. Ann Parasitol. 2014; 60 (3): 207-213.

  22. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003; 66 (3): 253-262.

  23. Santos RCS, Dias RS, Giordani AJ, Segreto RA, Segreto HR. Mucositis in head and neck cancer patients undergoing radiochemotherapy. Rev Esc Enferm USP. 2011; 45 (6): 1338-1344.

  24. Ruo Redda MG, Allis S. Radiotherapy-induced taste impairment. Cancer Treat Rev. 2006; 32 (7): 541-547.

  25. Yamashita H, Nakagawa K, Tago M, Nakamura N, Shiraishi K, Eda M et al. Taste dysfunction in patients receiving radiotherapy. Head Neck. 2006; 28 (6): 508-516.

  26. Rubira M, Devides N, Úbeda L, Bortolucci Jr A, Lauris J, Rubira-Bullen I et al. Evaluation of some oral postradiotherapy sequelae in patients treated for head and neck tumors. Braz Oral Res. 2015; 21 (3): 272-277.

  27. Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KB, Elting LS et al. Systematic review of dysgeusia induced by cancer therapies. Support Care Cancer. 2010; 18 (8): 1081-1087.

  28. Wranicz P, Herlofson BB, Evensen JF, Kongsgaard UE. Prevention and treatment of trismus in head and neck cancer: a case report and a systematic review of the literature. Scandinavian Journal of Pain. 2010; 1 (2): 84-88.

  29. Azcona V, Reyes J, Maldonado F. Incidencia de trismus en pacientes con cáncer de cavidad oral post-radioterapia. Rev Sanid Milit Mex. 2011; 65 (6): 277-283.

  30. Lee R, Slevin N, Musgrove B, Swindell R, Molassiotis A. Prediction of post-treatment trismus in head and neck cancer patients. Br J Oral Maxilofac Surg. 2012; 50 (4): 328-332.

  31. Bueno AC, Ferreira RC, Cota LO, Silva GC, Magalhães CS, Moreira AN. Comparison of different criteria for periodontitis case definition in head and neck cancer individuals. Support Care Cancer. 2015; 23 (9): 2599-2604.

  32. Laheij AM, de Soet JJ. Can the oral microflora affect oral ulcerative mucositis? Curr Opin Support Palliat Care. 2014; 8 (2): 180-187.

  33. Khaw A, Liberali S, Logan R, Keefe D, Bartold PM. Influence of periodontitis on the experience of oral mucositis in cancer patients undergoing head and neck radiotherapy: a pilot study. Supp Care Cancer. 2014; 22 (8): 2119-2125.

  34. Ammajan RR, Joseph R, Rajeev R, Choudhary K, Vidhyadharan K. Assessment of periodontal changes in patients undergoing radiotherapy for head and neck malignancy: a hospital-based study. J Cancer Res Ther. 2013; 9 (4): 630-637.

  35. Öztekin G, Baser U, Kucukcoskun M, Tanrikulu-Kucuk S, Ademoglu E, Isik G et al. The association between periodontal disease and chronic obstructive pulmonary disease: a case control study. COPD. 2014; 11 (4): 424-430.

  36. Bokhari SA, Khan AA, Leung WK, Wajid G. Association of periodontal and cardiovascular diseases: South-Asian studies 2001-2012. J Indian Soc Periodontol. 2015; 19 (5): 495-500.

  37. Peñaloza R (Director General) y col. IV estudio nacional de salud bucal- ENSAB IV: Situación en Salud Bucal. [Internet]. Bogotá, D.C: MinSalud; 2012 [citado 14 de noviembre de 2015] p. 381 p. Recuperado a partir de: http://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENSAB-IV-Situacion-Bucal-Actual.pdf

  38. Caribé F, Chimenos E, López J, Finestres F, Guix-Melcior B. Manejo odontológico de las complicaciones de la radioterapia y quimioterapia en el cáncer oral. Med Oral. 2003; 8: 178-187.

  39. Silvestre F, Plaza C, Serrano M. Prevención y tratamiento de las complicaciones orales derivadas de la radioterapia en pacientes con tumores de cabeza y cuello. Med Oral. 1998; 3: 136-147.

  40. Jham B, da Silva Freire A. Oral complications of radiotherapy in the head and neck. Rev Bras Otorrinolaringol. 2006; 72: 1007-1021.

  41. Hong CH, Napeñas JJ, Hodgson BD, Stokman MA, Mathers-Stauffer V, Elting LS et al. A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer. 2010; 18 (8): 1007-1021.

  42. Tolentino ES, Centurion BS, Ferreira LH, Souza AP, Damante JH, Rubira-Bullen IR. Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci. 2011; 19: 448-454.

  43. Vissink A, Burlage FR, Spijkervet FK, Jansma J, Coppes RP. Prevention and treatment or the consequences of head and neck radiotnerapy. Crit Rev Oral Biol Med. 2003; 14 (3): 213-225.

  44. Sabater M, Rodríguez de Rivera M, López J, Chimenos E. Manifestaciones orales secundarias al tratamiento oncológico: Pautas de actuación odontológica. Av Odontoestomatol. 2015; 22 (6): 335-342.

  45. Ord R, Blanchaert J. Oral cancer: the dentist’s role in diagnosis, management, rehabilitation, and prevention. Chicago: Quintessence Publishing Company; 2000.

  46. Casariego Z. La participación del odontólogo en el control del cáncer oral: Manejo en la prevención, tratamiento y rehabilitación. Av Odontoestomatol. 2015; 25 (5): 265-285.

  47. Lanza D. Tratamiento odontológico integral del paciente oncológico: Parte I. Odontoestomatología. 2015; 13 (17): 14-25.

  48. Congreso Colombia. Ley 1384: «Ley Sandra Ceballos, por la cual se establecen las acciones para la atención integral del cáncer en Colombia». abril de 2010.

  49. Secretaría de Salud-Bogotá. Guías de práctica clínica en salud oral. [Internet]. 2010 [citado 15 de noviembre de 2015]. Recuperado a partir de: http://www.saludcapital.gov.co/SUBS/Documents/Guias%202011.pdf

  50. Applebaum E, Ruhlen TN, Kronenberg FR, Hayes C, Peters ES. Oral cancer knowledge, attitudes and practices: a survey of dentists and primary care physicians in Massachusetts. J Am Dent Assoc. 2009; 140 (4): 461-467.

  51. Honarmand M, Hajihosseini A, Akbari F. Oral cancer knowledge of senior dental students in Zahedan, South-East of Iran. Asian Pac J Cancer Prev. 2014; 15 (7): 3017-3020.

  52. Dumitrescu A, Ibric S, Ibric-Cioranu V. Assessing oral cancer knowledge in Romanian undergraduate dental students. J Cancer Educ. 2014; 29 (3): 506-513.

  53. Awan KH, Khang TW, Yee TK, Zain RB. Assessing oral cancer knowledge and awareness among Malaysian dental and medical students. J Cancer Res Ther. 2014; 10 (4): 903-907.

  54. Al-Maweri SA, Abbas A, Tarakji B, Al-Jamaei A, Alaizari N, Al-Shamiri H. Knowledge and opinions regarding oral cancer among Yemeni dental students. Asian Pac J Cancer Prev. 2015; 16 (5): 1765-1770.




2020     |     www.medigraphic.com